Drug for treating bronchitis and bronchial asthma of 7-15 year old children

The invention relates to a drug for treating bronchitis and bronchial asthma of 7-15 year old children, which consists of oral Chinese medicinal decoction and acupuncture point injection. The active ingredients of Chinese medicinal decoction consists of a variety of Chinese herbal medicines, comprising Herba Ephedrae Praeparata, Schisandra chinensis, Astragalus mongholicus, American ginseng, Radix Pseudostellariae, a pair of gecko, Zaocys dhumnades, Morinda officinalis, Lumbricus, Herba Epimedii, Sinapis alba, Semen Descurainiae (Lepidium apetalum and/or Descurainia sophia), Ginkgo biloba seed, Ramulus Cinnamomi, Radix Paeoniae Alba, Radix Rehmanniae Praeparata, Fructus Psoralea, Achyranthes bidentata, Fructus Lycii, black ant, Poria cocos, Largehead Atractylodes Rhizome, Rhizoma Dioscoreae, Radix Glycyrrhizae, Scorpion, Divaricate saposhnikovia root, Belamcanda chinensis, Prunus mume, white mulberry root-bark, processed Tussilago farfara flower, Stemona Root, Lily Bulb, Semen Armeniacae Amarum, Ganoderma, Manchurian wildginger, Angelica sinensis, Cornus officinalis and Bombyx Batryticatus (Bombyx mori and/or Beauveria bassiana). The acupuncture point injection is one of nucleotide and casein, placenta tissue fluid and Astragalus mongholicus injection. The drug of the invention can treat both principal and secondary aspects of disease, determine the treatment based on differentiation of symptoms and signs, enhance body immunity, and recover the function of impaired lung, spleen, kidney and heart, and has the advantages of high cure rate and no recurrence.